A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Alpha Tau Medical (NASDAQ: DRTS) is an oncology-focused medical technology company developing alpha-radiation therapies designed to target and destroy solid tumors while minimizing damage to surrounding healthy tissue. The company's proprietary Alpha DaRT technology...
Alpha Tau Medical (Nasdaq: DRTS) is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into solid tumors. This fireside chat was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
Alpha Tau (Nasdaq: DRTS) is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into solid tumors. This company webcast was recorded during the Lytham Partners Fall 2025 Investor Conference.